Serotonin2 receptors and the serotonin transporter in the schizophrenic brain

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 169-175

  Dean, Brian ^a,b   Hayes, Wendy ^a   Opeskin, Kenneth ^a,c   Naylor, Lee ^a,b   Pavey, Geoffrey ^a   Hill, Christine ^a   Keks, Nicholas ^a,d   Copolov, David L ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c The Victorian Institute of Forensic Pathology ^*  (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

Caudate nucleus; Frontal cortex; Hippocampus; Paroxetine; Schizophrenia; Serotonin receptor; Serotonin transporter

Indexed keywords

CARRIER PROTEIN; KETANSERIN; MEMBRANE PROTEIN; NERVE PROTEIN; PAROXETINE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, HUMAN; SEROTONIN 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LEVEL; CAUDATE NUCLEUS; FEMALE; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; KINETICS; MALE; MEMBRANE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREFRONTAL CORTEX; SCHIZOPHRENIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN TISSUE; PRIORITY JOURNAL; SUICIDE;

ADOLESCENT; ADULT; AGED; BRAIN CHEMISTRY; CARRIER PROTEINS; CAUDATE NUCLEUS; FEMALE; HIPPOCAMPUS; HUMANS; KETANSERIN; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MEMBRANES; MIDDLE AGED; NERVE TISSUE PROTEINS; PAROXETINE; PREFRONTAL CORTEX; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029665348     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00091-5     Document Type: Article

References (28)

1. The economic costs of schizophrenia
2. 2) receptor binding in the frontal cortex of schizophrenic patients
3. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue
4. Neurotransmitter receptors in frontal cortex of schizophrenics
5. 2 receptor binding sites in depressed suicide victims
6. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
7. 2 receptor binding in patients with chronic schizophrenia
8. Clozapine: progress in treating refractory schizophrenia
9. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties
10. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics
11. Serotonin dopamine and their interactions in schizophrenia
12. Clinical studies of antipsychotic agents: implications for neurotransmitter mechanisms
13. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study
14. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites
15. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides
16. Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicides
17. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter
18. [3H]Ketanserin (R41468), a selective 3H-ligand for serotonin S2 receptor binding sites
19. 3H-paroxetine binding to platelets from healthy volunteers
20. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies
21. Neurochemical studies of violent and nonviolent suicide
22. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes
23. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
24. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine
25. 2 receptors and their involvement in schizophrenia and neuroleptic drug action
26. Tritiated LSD binding in frontal cortex in schizophrenia